Assignee
TAIWANJ PHARMACEUTICALS CO LTD
TW·6 granted patents·6 pending applications·16 citations·filing 2016–2025
Top patents by PatentIndex Score
12 records- 0187US10045977B2Use of nalmefene in non-alcoholic steatohepatitisTAIWANJ PHARMACEUTICALS CO LTD·Filed 2017·Granted Aug 14, 2018·16 cites·24 claims
- 0258US2026085046A1Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase InhibitionTAIWANJ PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0350US11661400B2NADPH oxidase inhibitors, pharmaceutical composition comprising the same, and application thereofTAIWANJ PHARMACEUTICALS CO LTD·Filed 2019·Granted May 30, 2023·0 cites·5 claims
- 0448US11130771B2Prodrugs of Naltrexone, Nalmefene and derivatives thereofTAIWANJ PHARMACEUTICALS CO LTD·Filed 2019·Granted Sep 28, 2021·0 cites·16 claims
- 0547US2020352867A1Pharmaceutical formulation for a solid dosage form of opioid receptor antagonistsTAIWANJ PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 0646US12162820B2Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the sameTAIWANJ PHARMACEUTICALS CO LTD·Filed 2020·Granted Dec 10, 2024·0 cites·21 claims
- 0744US11091421B2Benzene fused heterocyclic derivative and pharmaceutical composition comprising the sameTAIWANJ PHARMACEUTICALS CO LTD·Filed 2018·Granted Aug 17, 2021·0 cites·12 claims
- 0839US2020157088A1Benzene fused heterocyclic compound and use thereofTAIWANJ PHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 0939US2021130316A1Morphinan derivatives and compositions comprising the same for treating autoimmune, inflammation or infection related disordersTAIWANJ PHARMACEUTICALS CO LTD·Filed 2017·Application pending·0 cites
- 1035US2018318290A1Use of nalmefene in non-alcoholic steatohepatitisTAIWANJ PHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 1132US9757372B2Toll-like receptor 4 antagonists and use in autoimmune liver diseasesTAIWANJ PHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 12, 2017·0 cites·13 claims
- 1230US2020247761A1Sulfonamide or amide compounds, compositions and methods for the prophylaxis and/or treatment of autoimmune, inflammation or infection related disordersTAIWANJ PHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TAIWANJ PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →